NCT00060203
Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma treatment 1 / 2 completed NCT00004903
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma treatment 2 unknown_status NCT00003603
Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma treatment 3 unknown_status NCT00003490
Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma treatment 2 completed NCT00935090
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer No drug interventions diagnostic Not Available recruiting NCT00964821
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant No drug interventions Not Available Not Available completed NCT00017602
Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 3 completed NCT00002502
Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome treatment 2 completed NCT00293384
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant supportive_care Not Available completed NCT00445484
Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 2 completed NCT01137643
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer No drug interventions Not Available Not Available recruiting NCT00003687
Treatment for Chronic Pain in Patients With Advanced Cancer supportive_care 3 completed NCT00005987
Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma treatment 2 terminated NCT00365287
Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer treatment 1 / 2 completed NCT00003887
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation No drug interventions treatment 2 completed NCT00635154
Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma treatment 2 completed NCT00044954
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00005854
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00082654
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients No drug interventions Not Available Not Available completed NCT00899951
Studying Fentanyl in Patients With Cancer Not Available Not Available terminated NCT00301951
Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer treatment 1 completed NCT00002653
Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma treatment 3 unknown_status NCT00003853
4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis No drug interventions treatment 2 completed NCT00747877
High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy treatment 3 unknown_status NCT00084747
Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma treatment 1 / 2 completed NCT00335647
Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma treatment 1 / 2 completed NCT00618345
Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 2 completed NCT00566098
Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma treatment 1 / 2 completed NCT00317798
Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma treatment 1 completed NCT00003398
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 4 completed NCT00003805
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count supportive_care 3 completed NCT00005805
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer No drug interventions supportive_care 3 completed NCT00416897
Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure treatment 3 completed NCT00946283
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome No drug interventions supportive_care Not Available terminated NCT00937183
Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma No drug interventions treatment Not Available completed NCT00317811
Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma treatment 2 completed NCT00064311
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation supportive_care 1 / 2 completed NCT00109993
Campath-1H + FK506 and Methylprednisolone for GVHD supportive_care 2 completed NCT00477971
Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis treatment 3 completed NCT00002878
Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 3 completed NCT00002678
Combination Chemotherapy in Treating Patients With Multiple Myeloma treatment 3 completed NCT00482378
Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain treatment 1 / 2 completed NCT00004088
Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma treatment 2 completed NCT00002907
Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma treatment 2 completed NCT00003007
Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma treatment 2 completed NCT00003107
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors treatment 1 completed NCT00008307
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders treatment 2 unknown_status NCT01164709
Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer treatment 1 completed NCT00569309
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma treatment Not Available completed NCT00750009
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial No drug interventions other 3 completed NCT00952185
Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers No drug interventions supportive_care Not Available terminated NCT00003885
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma treatment 2 unknown_status NCT00544115
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders treatment 2 active_not_recruiting NCT00772915
Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma treatment 2 completed NCT00691015
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant supportive_care 2 completed NCT00477815
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma treatment 1 completed NCT00089037
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation supportive_care 1 / 2 completed NCT00245037
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer treatment 1 / 2 completed NCT00033332
Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma treatment 3 completed NCT00004232
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer supportive_care 1 completed NCT00005852
Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant treatment 2 terminated NCT00003600
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy supportive_care 3 completed NCT00021359
Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma treatment 2 completed NCT00478075
Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 1 / 2 completed NCT00176475
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease treatment 1 terminated NCT00006042
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT00002742
Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer supportive_care 3 completed NCT00002599
Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma treatment 3 unknown_status NCT00661999
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer supportive_care 3 completed NCT00900406
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant No drug interventions Not Available Not Available completed NCT00602706
Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant treatment 1 / 2 completed NCT00258206
Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma treatment 2 completed NCT00003149
Interleukin-12 in Treating Patients With Multiple Myeloma treatment 2 completed NCT00045136
Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma treatment 1 / 2 completed NCT00004036
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer supportive_care 1 unknown_status NCT01118013
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant treatment 2 terminated NCT00304018
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer treatment 1 completed NCT00478218
Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma treatment 2 completed NCT00006019
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer treatment 2 completed NCT00376519
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases treatment 1 terminated NCT00814541
PAD. ICORG 05-01, V11 treatment 2 completed NCT00438841
Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma treatment 2 unknown_status NCT00005641
Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation treatment 2 terminated NCT00003341
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy supportive_care 3 completed NCT00134017
Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer treatment 2 completed NCT00608517
Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil treatment Not Available terminated NCT00005634
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy treatment 1 completed NCT00324324
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant supportive_care 3 terminated NCT00008216
Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer No drug interventions Not Available Not Available terminated NCT00003396
Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00558896
CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis treatment 2 completed NCT00004158
Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma treatment 1 / 2 completed NCT00004058
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder treatment 1 terminated NCT00258258
Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders treatment 1 terminated NCT00589563
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer supportive_care 2 completed NCT00024063
SU006668 in Treating Patients With Advanced Solid Tumors treatment 1 unknown_status NCT00028886
Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma treatment 3 unknown_status NCT00004239
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment treatment 1 terminated NCT00376922
Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases No drug interventions supportive_care Not Available completed NCT00458822
Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis treatment 2 completed NCT00006225
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer treatment 1 / 2 completed NCT01137825
Registry of Older Patients With Cancer No drug interventions Not Available Not Available recruiting NCT00313625
Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma treatment 2 completed NCT00080925
T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies treatment 1 completed NCT00521430
Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease treatment Not Available completed NCT00002630
High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse treatment 2 completed NCT00006348
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment supportive_care 3 completed NCT00448357
Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen treatment 1 / 2 completed NCT00423826
Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease Not Available Not Available no_longer_available NCT00004165
Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma treatment 3 completed NCT00687674
Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 1 terminated NCT00900120
Collecting and Storing Blood Samples From Patients With Cancer No drug interventions Not Available Not Available withdrawn NCT00941720
Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma treatment 2 completed NCT00022282
AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 2 completed NCT00014482
Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation No drug interventions Not Available Not Available completed NCT00003082
Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer No drug interventions treatment 1 completed NCT00062231
Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer supportive_care Not Available terminated NCT00058331
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors supportive_care 3 completed NCT00237627
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer treatment 1 / 2 completed NCT00003960
Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00027560
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer treatment 2 completed NCT00369291
CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant treatment 1 terminated NCT00003962
Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT00725062
Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant No drug interventions treatment 1 terminated NCT00568880
Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 1 completed NCT00474929
Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma treatment 1 / 2 completed NCT00567229
Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma treatment 2 terminated NCT00002989
Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome treatment 3 unknown_status NCT00564889
Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis treatment 2 completed NCT00005092
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT00316940
Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 1 completed NCT00004040
Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy treatment 2 withdrawn NCT00806767
Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer treatment 2 completed NCT00389701
Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment treatment 2 unknown_status NCT00281801
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation No drug interventions Not Available Not Available completed NCT00134004
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer treatment 2 completed NCT00005804
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00002504
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer treatment 2 completed NCT00008268
Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma treatment 2 completed NCT00900068
Blood Samples From Patients on a Clinical Trial to CINV During HSCT No drug interventions Not Available Not Available terminated NCT00017069
Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma treatment 2 terminated NCT00305812
Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma treatment 2 completed NCT00301912
Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer treatment 2 withdrawn NCT00002810
High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis treatment 2 completed NCT00897910
Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma No drug interventions Not Available Not Available terminated NCT00255710
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer supportive_care 1 completed NCT00004181
Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia treatment 2 completed NCT00007995
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis treatment 2 completed NCT00003395
Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer treatment 1 completed NCT00003195
Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma treatment 2 completed NCT00060255
High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors treatment 2 completed NCT00900055
Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma No drug interventions Not Available Not Available completed NCT00477750
Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma treatment 1 / 2 completed NCT00296023
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer treatment Not Available completed NCT00068523
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies treatment Not Available completed NCT00003408
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer treatment 2 completed NCT00516503
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer supportive_care 3 completed NCT00006890
Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma treatment 2 completed NCT00036790
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer treatment 1 completed NCT00008164
Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia No drug interventions treatment 2 unknown_status NCT00006021
Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma treatment 1 / 2 completed NCT00004902
Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma treatment 2 completed NCT00052884
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation treatment 1 terminated NCT00281879
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer treatment 2 terminated NCT00006379
Non-Ablative Allo HSCT For Hematologic Malignancies or SAA treatment 2 completed NCT00017433
Arsenic Trioxide in Treating Patients With Multiple Myeloma treatment 2 terminated NCT00003554
Rituximab in Treating Patients With Multiple Myeloma treatment 2 completed NCT00744354
Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 1 terminated NCT00003451
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer treatment 1 completed NCT00611351
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer treatment 2 completed NCT00003353
High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis treatment 2 completed NCT00003153
Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation treatment 2 completed NCT00003077
Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss No drug interventions supportive_care 1 / 2 completed NCT00499577
Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma No drug interventions treatment 1 / 2 completed NCT00602147
Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan No drug interventions Not Available Not Available terminated NCT00004145
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00619645
Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers treatment 2 completed NCT00258245
Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia treatment 1 completed NCT00006098
PS-341 in Treating Patients With Hematologic Cancer treatment 1 completed NCT00458705
Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma treatment 2 completed NCT00295997
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia treatment Not Available unknown_status NCT00006083
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter supportive_care 3 completed NCT00010283
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon supportive_care 1 / 2 completed NCT00787761
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer treatment 2 completed NCT00290628
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer treatment Not Available terminated NCT00288028
Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant treatment 1 completed NCT00666211
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain No drug interventions supportive_care 3 completed NCT00716911
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant supportive_care Not Available completed NCT00003493
Combination Chemotherapy in Treating Patients With Multiple Myeloma treatment 2 completed NCT00470093
Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma treatment 0 terminated NCT00022607
Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 2 completed NCT00962507
Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma treatment 1 completed NCT00265837
Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer No drug interventions treatment 3 completed NCT00334932
Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma treatment 1 / 2 unknown_status NCT00006232
Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma treatment 3 completed NCT00004132
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer supportive_care 2 completed NCT01116232
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation supportive_care 2 terminated NCT00253552
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders treatment Not Available terminated NCT00046852
Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma treatment 1 / 2 completed NCT00002652
Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease treatment 2 completed NCT00002552
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma treatment 2 completed NCT00042900
Pyroxamide in Treating Patients With Advanced Cancer treatment 1 completed NCT00996359
Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation No drug interventions treatment 1 terminated NCT00003270
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00792142
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma treatment 2 completed NCT00008242
Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma treatment 2 completed NCT00424242
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases treatment 0 completed NCT00003399
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma treatment 2 completed NCT00066599
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy supportive_care 2 completed NCT00827099
Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer treatment 2 terminated NCT00005606
Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation No drug interventions treatment 2 completed NCT00453206
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases No drug interventions treatment Not Available completed NCT00003406
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer treatment 1 / 2 completed NCT00085449
Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer treatment 1 / 2 withdrawn NCT00255749
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer supportive_care 2 completed NCT00719849
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease treatment 2 terminated NCT00054236
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia treatment 1 completed NCT00006013
SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma treatment 2 completed NCT00534118
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant No drug interventions treatment Not Available completed NCT00002818
High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies treatment 1 completed NCT00006219
Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma prevention 2 completed NCT00770419
Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers No drug interventions Not Available Not Available withdrawn NCT00526734
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma treatment 2 unknown_status NCT00635024
Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma treatment 2 terminated NCT00823524
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer treatment 1 / 2 completed NCT00416624
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy supportive_care 2 completed NCT00651716
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant No drug interventions Not Available Not Available terminated NCT00003116
High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00612716
Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia treatment 2 completed NCT00482716
Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer supportive_care 3 unknown_status NCT00096096
Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation supportive_care 2 completed NCT00918658
Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer No drug interventions Not Available Not Available terminated NCT00054158
Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma treatment 2 completed NCT00432458
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma treatment 3 completed NCT00004258
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer treatment 1 completed NCT00003163
Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers treatment 2 unknown_status NCT00719563
American Ginseng in Treating Patients With Fatigue Caused by Cancer supportive_care 3 completed NCT00014339
Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma treatment 3 unknown_status NCT00942422
Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma No drug interventions treatment 2 terminated NCT00015925
MS-275 in Treating Patients With Hematologic Cancer treatment 1 completed NCT00248430
Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer treatment 1 / 2 completed NCT00726830
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer supportive_care Not Available terminated NCT00523848
Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma treatment 2 completed NCT00002657
SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant treatment 2 completed NCT00410657
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant supportive_care 2 completed NCT00938626
Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma treatment 1 completed NCT00951626
A Standardized Nursing Intervention Protocol for HCT Patients No drug interventions health_services_research Not Available completed NCT00898066
S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease No drug interventions Not Available Not Available completed NCT00006466
Beta Alethine in Treating Patients With Myeloma treatment 1 / 2 unknown_status NCT00049374
Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 2 completed NCT00513474
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant supportive_care 1 completed NCT00616720
Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma treatment 2 completed NCT00469820
Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant No drug interventions treatment 1 terminated NCT00006220
Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy treatment 1 / 2 terminated NCT00227682
Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 2 terminated NCT00070382
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer supportive_care 3 completed NCT00003331
Combination Chemotherapy in Treating Patients With Advanced Cancer treatment 1 completed NCT00049673
Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma treatment 3 completed NCT00993694
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone Not Available Not Available completed NCT00006362
PS-341 in Treating Patients With Advanced Cancer treatment 1 completed NCT00899080
Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide No drug interventions Not Available Not Available completed NCT00002980
Decitabine in Treating Patients With Melanoma or Other Advanced Cancer treatment 1 completed NCT00008229
Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma treatment 3 completed NCT00053989
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders treatment 2 completed NCT01077440
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant No drug interventions Not Available Not Available terminated NCT00755040
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder prevention 3 completed NCT00898040
Study of DNA Samples From Patients With Multiple Myeloma No drug interventions Not Available Not Available completed NCT00740467
Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders treatment 2 unknown_status NCT00089167
Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis treatment 2 completed NCT00609167
Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma treatment 2 completed NCT00005967
Tipifarnib in Treating Patients With Advanced Hematologic Cancer treatment 1 completed NCT00637767
High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant treatment 2 terminated NCT00504101
Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma treatment 1 withdrawn NCT00003401
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma treatment 2 completed NCT00813501
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases No drug interventions Not Available Not Available terminated NCT00448201
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease treatment 2 completed NCT00004904
Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 1 completed NCT00742404
Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma treatment 2 unknown_status NCT00004072
O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma treatment 2 completed NCT00003572
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers treatment 2 completed NCT00378768
Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma No drug interventions treatment 2 completed NCT00499668
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer supportive_care Not Available withdrawn NCT00802568
Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment treatment 2 completed NCT00005946
Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation treatment 1 completed NCT00602446
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant supportive_care 2 terminated NCT00003146
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma treatment 2 completed NCT01101412
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies supportive_care 1 / 2 withdrawn NCT00036712
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation No drug interventions supportive_care 2 unknown_status NCT00482495
Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma treatment 2 completed NCT00281814
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant No drug interventions Not Available Not Available completed NCT00006350
Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer treatment 2 completed NCT00800150
Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment treatment 1 terminated NCT00104923
Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer treatment 1 completed NCT00014508
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma treatment 2 completed NCT00445666
Tumor-Infiltrating Lymphocytes in Treating Patients With Persistent or Recurrent B-Cell Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Multiple Myeloma After a Previous Donor Stem Cell Transplant No drug interventions treatment 1 active_not_recruiting